Why are researchers still fumbling in the quest to cure what is arguably one of the most important diseases confronting humankind—Alzheimer's disease? Despite decades of research, there is still no ...
Alpha Cognition's ZUNVEYL, FDA-approved in July 2024, targets Alzheimer's with improved tolerability over existing galantamine therapies. ZUNVEYL's pricing is competitive versus newer Alzheimer's ...
A university is leading research into how daffodils can help improve dementia treatment. The Royal Agricultural University (RAU), based in Cirencester in Gloucestershire, is working with Welsh ...
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition” or the “Company”), a commercial-stage biopharmaceutical company focused on developing ...
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (NASDAQ: ACOG) (the “Company” or “Alpha Cognition”) today announced three upcoming presentations at the 2025 Alzheimer’s ...
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)-- Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today ...
Daffodils have been used in traditional and folk medicine for centuries, but its most recent contribution to human health is surprisingly connected to Alzheimer’s. The cheery spring flower contain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results